EML4 Deficiency Causes Alveolar Macrophage Dysfunction and Interstitial Lung Disease

We report a novel inborn error of immunity in two siblings born to consanguineous parents who presented with short stature, failure to thrive, eosinophilic esophagitis, severe eczema, and early onset, progressive interstitial lung disease with lipoid pneumonia or pulmonary alveolar proteinosis (PAP)-like features. Genetic testing revealed both affected siblings harbored a homozygous deletion of a region of the EML4 gene, which encodes for echinoderm microtubule-associated protein-like 4 (EML4). Further analysis confirmed a lack of EML4 RNA or protein expression. EML4 deficiency has not been reported in the literature and very little is known about its physiological function. Thus, we generated EML4-deficient mice by CRISPR/Cas9 gene editing of EmL4 to examine the role of EML4 in immune function and lung disease. Consistent with the short stature of the patients, EML4-deficient mice were runted compared with wild-type (WT) mice. We also examined the lungs of EML4-deficient mice, particularly the alveolar macrophage (AMs) population, as defects in AM number or function are known to be associated with PAP. This revealed that EML4-deficient mice had significantly decreased alveolar macrophages (AMs) compared with WT mice, but no change in the frequencies of other immune cell populations. scRNA-seq demonstrated that among lung cells, EML4 deficiency had the greatest impact on the gene expression program of AMs. EML4-deficient AMs also showed increased lipid accumulation consistent with the foamy macrophages observed in the bronchioalveolar lavage of the patients. Under specific pathogen–free (SPF) conditions, EML4-deficient mice did not demonstrate lung pathology or fibrosis. However, colonization of EML4-deficient mice with more diverse microbiota by cohousing with “dirty” mice led to florid immune infiltration and fibrosis. Together, our results reveal that EML4 deficiency results in defects in AM which combined with microbial exposure may trigger inappropriate inflammatory responses and subsequent lung fibrosis.

Authors

Institutions

Publication Details

Journal
Journal of Human Immunity
Published
2025-04-25
DOI
https://doi.org/10.70962/cis2025abstract.112
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EML4 Deficiency Causes Alveolar Macrophage Dysfunction and Interstitial Lung Disease

Paul Gray, Elissa K. Deenick, Robert Brink, Shruti Swamy et al.
1 links
Journal of Human Immunity
Neonatal Respiratory Health Research
article

EML4 Deficiency Causes Alveolar Macrophage Dysfunction and Interstitial Lung Disease

Paul Gray, Elissa K. Deenick, Robert Brink, Shruti Swamy, Peter Hsu, Chetan Pandit
article en

Abstract

We report a novel inborn error of immunity in two siblings born to consanguineous parents who presented with short stature, failure to thrive, eosinophilic esophagitis, severe eczema, and early onset, progressive interstitial lung disease with lipoid pneumonia or pulmonary alveolar proteinosis (PAP)-like features. Genetic testing revealed both affected siblings harbored a homozygous deletion of a region of the EML4 gene, which encodes for echinoderm microtubule-associated protein-like 4 (EML4). Further analysis confirmed a lack of EML4 RNA or protein expression. EML4 deficiency has not been reported in the literature and very little is known about its physiological function. Thus, we generated EML4-deficient mice by CRISPR/Cas9 gene editing of EmL4 to examine the role of EML4 in immune function and lung disease. Consistent with the short stature of the patients, EML4-deficient mice were runted compared with wild-type (WT) mice. We also examined the lungs of EML4-deficient mice, particularly the alveolar macrophage (AMs) population, as defects in AM number or function are known to be associated with PAP. This revealed that EML4-deficient mice had significantly decreased alveolar macrophages (AMs) compared with WT mice, but no change in the frequencies of other immune cell populations. scRNA-seq demonstrated that among lung cells, EML4 deficiency had the greatest impact on the gene expression program of AMs. EML4-deficient AMs also showed increased lipid accumulation consistent with the foamy macrophages observed in the bronchioalveolar lavage of the patients. Under specific pathogen–free (SPF) conditions, EML4-deficient mice did not demonstrate lung pathology or fibrosis. However, colonization of EML4-deficient mice with more diverse microbiota by cohousing with “dirty” mice led to florid immune infiltration and fibrosis. Together, our results reveal that EML4 deficiency results in defects in AM which combined with microbial exposure may trigger inappropriate inflammatory responses and subsequent lung fibrosis.

Journal of Human ImmunityVol. 1(CIS2025)
Garvan Institute of Medical Research (AU), Royal Prince Alfred Hospital (AU), Royal North Shore Hospital (AU), Children's Hospital at Westmead (AU), UNSW Sydney (AU), Sydney Children's Hospital (AU)
Openalex Percentile: Top 87%
Neonatal Respiratory Health Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.